Former Sen. Ben Sasse gives a glimpse of what it's like to be a participant in an tough but promising new drug for pancreatic ...

Dana-Farber CEO Benjamin Ebert has no shortage of ideas and vision for the cancer institute as it untangles from Mass General ...

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

The FDA told more than 2,200 companies and researchers that they are required to report clinical trial results, or they may ...

The director of WHO's Eastern Mediterranean region is weighing whether to run to be the next director-general at a time of ...

Yesterday, we got highly promising results from a trial of Revolution Medicines’ pancreatic cancer pill, showing that ...

Hospitals offer their own chatbots, Medicare's ACCESS pilot, and an update Utah's 'AI doctor' experiment.

An experimental Medicare program, how family dynamics affect brain recovery, and other health news from Morning Rounds ...

Grant is an M.D./M.B.A. student at Harvard Medical School and Harvard Business School, a researcher at Boston Children’s ...

The board will now oversee a process to lower the cost of the type 2 diabetes medicine Jardiance by January 2027.

FDA officials said an internal analysis found results were not submitted for nearly 30% of studies “highly likely” to fall ...

We watched the Artemis II astronauts splash down safely last week. A reminder that legitimately amazing things can still ...